Prostate specific antigen predicts the long-term risk of prostate enlargement: Results from the Baltimore Longitudinal Study of Aging

Journal of Urology

Volumn 167, Issue 6, 2002, Pages 2484-2487

  Wright, E James ^a   Fang, Junyong ^a   Metter, E Jeffrey ^a   Partin, Alan W ^a   Landis, Patricia ^a   Chan, Daniel W ^a   Carter, H Ballentine ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate; Prostate specific antigen; Prostatic hyperplasia

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE; OUTCOMES RESEARCH; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REGRESSION ANALYSIS; RISK ASSESSMENT;

EID: 0036096870     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65010-0     Document Type: Article

References (11)

1. Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men?
2. Natural history of prostatism: Risk factors for acute urinary retention
3. Serum prostate specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia
4. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia
5. Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease
6. Prostatic growth rate determined from MRI data: Age-related longitudinal changes
7. Association of health-related quality of life and benign prostatic enlargement
8. Prostate cancer prevention trial (PCPT) update
9. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia